Frozen Section: A Vital Tool in Surgical Pathology

Liu Caifeng^*
*Correspondence: Liu Caifeng, Department of Clinical Pathology, University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China, Email:

Keywords

Real-time diagnosis • Lesion • Optimal patient care

Introduction

In the realm of surgical pathology, time is often a critical factor. Surgeons need immediate and accurate information about tissue samples during an operation to make informed decisions. Frozen section analysis, a technique that allows for rapid intraoperative histopathological examination of tissue, has emerged as an invaluable tool in modern medicine. This article delves into the intricacies of frozen section procedures, its applications, advantages, limitations, and the evolving landscape of this indispensable diagnostic technique. Frozen section, also known as cryosection or intraoperative consultation, is a histopathological technique that involves the rapid freezing and sectioning of tissue samples obtained during surgery. The primary goal of frozen section analysis is to provide real-time diagnostic information to guide surgeons in making immediate decisions regarding the extent of surgical resection, margins, and overall patient management. The frozen section procedure begins with the acquisition of a tissue sample, typically from a suspected tumor or abnormal tissue. The pathologist then rapidly freezes the tissue using a cryostat, a specialized instrument that can maintain low temperatures while facilitating the slicing of frozen tissue sections. These thin sections are stained using specific dyes and examined under a microscope by a pathologist to determine the nature of the tissue (benign or malignant), assess margins, or identify specific pathological features [1].

One of the most common and critical applications of frozen section analysis is in oncological surgery. Surgeons rely on frozen sections to determine the nature of tumors and evaluate the presence of malignant cells at the margins of the resected tissue. This information allows them to decide whether further resection is necessary, potentially sparing healthy tissue and improving patient outcomes. In neurosurgery, where precision is paramount, frozen section analysis assists in distinguishing between normal brain tissue and tumor tissue. This is especially important when dealing with gliomas and other brain tumors, as the accurate identification of tumor boundaries helps minimize damage to healthy brain tissue. Frozen section analysis is also widely used in gynecological surgery, particularly in cases of ovarian and uterine malignancies. Surgeons can assess whether a tumor is benign or malignant and make informed decisions about the extent of surgery required, including the removal of lymph nodes. Orthopedic surgeons rely on frozen section analysis to confirm the diagnosis of bone and soft tissue tumors. This technique aids in deciding whether limb-sparing surgery is possible or if amputation is necessary to ensure complete removal of the tumor. Transplant surgeons utilize frozen section analysis to assess the quality of donor organ tissue before transplantation. This ensures that the organ is healthy and viable for transplantation, reducing the risk of graft failure. In pediatric surgery, where preserving healthy tissue is of utmost importance, frozen section analysis helps confirm the nature of lesions and guide surgical decision-making. This is particularly crucial in cases involving congenital abnormalities or tumors [2].

The most significant advantage of frozen section analysis is its ability to provide immediate results. Surgeons can receive crucial information about tissue samples within minutes, enabling them to adjust their surgical approach in real-time. This can lead to more precise surgeries, reduced operating times, and improved patient outcomes. Frozen section analysis allows for the assessment of surgical margins during the procedure. This is vital in oncological surgeries to ensure that all cancerous tissue is removed while preserving as much healthy tissue as possible. Accurate margin assessment reduces the likelihood of the need for re-operation. By providing surgeons with instant information about the nature of tissue samples, frozen section analysis helps reduce the re-operation rates, which can be emotionally and financially taxing for patients. Minimizing the need for re-operation also contributes to shorter hospital stays and quicker recoveries. In cases where a malignancy is confirmed during surgery, frozen section analysis allows for prompt decisions regarding the need for additional procedures, such as lymph node dissection, chemotherapy, or radiation therapy. This accelerates the initiation of appropriate treatment. For organ transplant recipients, frozen section analysis ensures that only healthy and viable donor organs are used. This improves the overall success rate of transplantation procedures and enhances the chances of longterm organ function. Frozen section analysis is based on a small, selected sample of tissue, and there is a risk of sampling error. The sampled area may not accurately represent the entire lesion, leading to misdiagnosis [3].

Literature Review

The freezing process can introduce artifacts, which are abnormalities or distortions in tissue structure. These artifacts can sometimes make it challenging to accurately interpret frozen section slides. Frozen section analysis provides limited information compared to Formalin-Fixed Paraffin-Embedded (FFPE) tissue analysis, which is the standard for comprehensive pathology. Some features, such as molecular profiling or immunohistochemistry, may not be accessible through frozen sections. Performing and interpreting frozen section analysis requires specialized training and expertise. Not all healthcare facilities may have access to experienced pathologists, potentially affecting the accuracy of the results. Advancements in cryostat technology, staining techniques, and imaging systems have improved the accuracy and reliability of frozen section analysis. Automated cryostats and digital microscopy are becoming increasingly common, enhancing the speed and efficiency of the procedure. While frozen section analysis traditionally focused on tissue morphology, recent developments have expanded its capabilities to include molecular testing. Pathologists can now perform rapid molecular tests on frozen samples, providing information about genetic mutations and biomarkers that can guide treatment decisions. Telepathology, which involves the remote interpretation of pathology slides, is gaining traction in frozen section analysis. This allows pathologists to consult with experts in real-time, even when they are not physically present in the operating room, improving access to specialized expertise [4].

Frozen section analysis has revolutionized the field of surgical pathology by providing rapid, on-the-spot diagnostic information to guide surgical decision-making. Its applications span various surgical disciplines, from oncology to transplantation, and its advantages in terms of real-time decisionmaking and margin assessment cannot be overstated. However, it is essential to acknowledge its limitations and the need for expertise in performing and interpreting frozen section analysis. As technology continues to advance, frozen section analysis is likely to become even more precise and versatile, with the integration of molecular testing and telepathology. While it may never fully replace traditional histopathology, frozen section analysis will remain a vital tool in the arsenal of healthcare professionals, ensuring that surgeries are as precise, efficient, and patient-centered as possible. Maintaining high-quality frozen section services is essential for its success. Laboratories performing frozen sections must adhere to strict quality control measures to minimize errors. This includes ensuring proper tissue handling, freezing, staining, and slide preparation. The equipment and personnel required for frozen section analysis can be costly. Smaller healthcare facilities may face financial challenges in implementing and sustaining this service. Balancing the costeffectiveness with the clinical benefits is an ongoing concern. As mentioned earlier, expertise is critical for the success of frozen section analysis [5].

Pathologists and laboratory personnel need specialized training to perform and interpret frozen sections accurately. Continuous education and training programs are vital to maintain proficiency. The integration of digital pathology into frozen section analysis is a promising avenue. Digital slides can be easily shared and archived, improving collaboration among pathologists and facilitating consultation with experts in remote locations. Artificial intelligence (AI) and machine learning are increasingly being explored to aid in the interpretation of frozen section slides. AI algorithms can assist pathologists in identifying and classifying tissue abnormalities more efficiently, potentially reducing the risk of human error. The future of frozen section analysis is closely tied to the overarching trend of patient-centered care. Minimizing the invasiveness of surgery, optimizing outcomes, and reducing healthcare costs remain paramount objectives. Frozen section analysis will continue to play a vital role in achieving these goals. Patients undergoing surgery where frozen section analysis may be employed should be informed about the procedure, its purpose, potential risks, and the possibility of additional surgery based on the results. Obtaining informed consent is essential to respecting patients' autonomy and ensuring they are actively involved in their healthcare decisions. Protecting patient confidentiality and data security is crucial, especially when using telepathology or digital pathology platforms. Healthcare institutions must have robust measures in place to safeguard patient information [6].

Discussion

The allocation of limited healthcare resources is an ethical consideration. Decisions regarding the availability of frozen section services, especially in resource-constrained settings, should prioritize clinical need and equity to ensure that the benefits are distributed fairly. The ethical challenge of balancing precision and speed in surgical decision-making exists. Rushing decisions based on frozen section results may lead to errors, while waiting for comprehensive pathology reports can potentially jeopardize a patient's condition. Striking the right balance is crucial. Frozen section analysis has undoubtedly transformed surgical practice by providing surgeons with rapid and critical information during operations. Its applications across various medical specialties, coupled with technological advancements, have made it an indispensable tool in modern medicine. While frozen section analysis offers numerous advantages, it is not without limitations and challenges. Ensuring high-quality services, addressing cost concerns, and prioritizing education and training are ongoing efforts in the field. As technology continues to evolve, the integration of digital pathology, artificial intelligence, and a patient-centered approach will shape the future of frozen section analysis.

Conclusion

Frozen section analysis remains an indispensable tool in the field of surgical pathology and continues to evolve in response to technological advancements and healthcare needs. Its real-time diagnostic capabilities have transformed surgical decision-making, enabling surgeons to provide more precise and patient-centered care. While challenges such as resource constraints and ethical considerations persist, the benefits of frozen section analysis are clear. By providing immediate information about tissue samples, guiding surgical decisions, and improving patient outcomes, this technique has earned its place as a cornerstone of modern surgical practice. As healthcare systems worldwide continue to prioritize quality, efficiency, and patient-centered care, the role of frozen section analysis is likely to expand further. With ongoing research, technological innovation, and a commitment to addressing disparities in access, the future of frozen section analysis holds promise in improving surgical outcomes and advancing the field of medicine.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Qiu, Si-Qi, Guo-Jun Zhang, Liesbeth Jansen and Jakob de Vries, et al. "Evolution in sentinel lymph node biopsy in breast cancer."Crit Rev Oncol /Hematol 123 (2018): 83-94.

Google Scholar, Crossref, Indexed at

2. Chao, Celia, Sandra L. Wong, Douglas Ackermann and Diana Simpson, et al. "Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer."Am J Surg 182 (2001): 609-615.

Google Scholar, Crossref, Indexed at

3. Gentilini, Oreste and Umberto Veronesi. "Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)."The Breast21 (2012): 678-681.

Google Scholar, Crossref, Indexed at

4. Marino, Maria Adele, Daly Avendano, Pedro Zapata and Christopher C. Riedl, et al. "Lymph node imaging in patients with primary breast cancer: Concurrent diagnostic tools."Oncol 25 (2020): e231-e242.

Google Scholar, Crossref, Indexed at

5. Cutuli, Bruno, Michel Velten and Caroline Martin. "Assessment of axillary lymph node involvement in small breast cancer: Analysis of 893 cases."Clin Breast Cancer 2 (2001): 59-65.

Google Scholar, Crossref, Indexed at

6. Holck, S., H. Galatius, U. Engel and F. Wagner, et al. "False-negative frozen section of sentinel lymph node biopsy for breast cancer."The Breast13 (2004): 42-48.

Google Scholar, Crossref, Indexed at